| Tag | Content |
|---|
EnhancerAtlas ID | HS139-00513 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr1:16273620-16274780 |
Target genes | |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF4 | MA0039.3 | chr1:16274137-16274148 | CCACACCCTCT | + | 6.02 | | TBX21 | MA0690.1 | chr1:16273857-16273867 | AAGGTGTGAA | + | 6.02 |
|
| | Number of super-enhancer constituents: 22 | ID | Coordinate | Tissue/cell |
| SE_01097 | chr1:16272091-16273926 | Adrenal_Gland | | SE_01097 | chr1:16274125-16275344 | Adrenal_Gland | | SE_01987 | chr1:16272432-16279631 | Aorta | | SE_02709 | chr1:16274610-16280662 | Astrocytes | | SE_03452 | chr1:16274147-16275217 | Brain_Angular_Gyrus | | SE_04408 | chr1:16274061-16278759 | Brain_Anterior_Caudate | | SE_05249 | chr1:16273948-16279656 | Brain_Cingulate_Gyrus | | SE_06124 | chr1:16270812-16279644 | Brain_Hippocampus_Middle | | SE_07342 | chr1:16272948-16278751 | Brain_Hippocampus_Middle_150 | | SE_08131 | chr1:16272535-16279679 | Brain_Inferior_Temporal_Lobe | | SE_18522 | chr1:16273733-16281386 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19255 | chr1:16273419-16281362 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_27189 | chr1:16274173-16281550 | Esophagus | | SE_36664 | chr1:16274460-16277822 | HMEC | | SE_40080 | chr1:16274659-16281418 | K562 | | SE_45001 | chr1:16274543-16280813 | NHLF | | SE_45986 | chr1:16274066-16281079 | Osteoblasts | | SE_47059 | chr1:16274282-16275296 | Ovary | | SE_55849 | chr1:16274274-16283539 | u87 | | SE_61132 | chr1:16274043-16303645 | HBL1 | | SE_64852 | chr1:16274416-16281190 | NHEK | | SE_67570 | chr1:16274274-16283539 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH01I015945 | chr1 | 16272092 | 16273926 | | GH01I015947 | chr1 | 16274011 | 16281336 |
|
Enhancer Sequence | ACCAAGGACA GGACAGCTGT CACAGACCCA CCTCAAGATC CGGCACCGGC AGCCTGCCCC 60
ACCACTCCAC TCAGCAGCAG GACGCAGGGA TTTAGGAACA GCTGAGTGGC AAGCCTGCAT 120
CGCCCCATCT CCTCTGTGGA GAGGAGGCAG GTAACCTGGG GGATCTCAGC ACTACCAACA 180
GCCCTTGAAA AGAAGTGCTC GCTGAGGGTC TGAATGCCTG CCCTGCACAG AGAACAAAAG 240
GTGTGAACGC CCACCCTGCA CAGAGGACAG GAGGTGTGAA TGCCCACACT GCACAGGGAA 300
CAGAAGGTGC AACTGTCCGC CCTGCATGGA GGAGGATGGG CTGTGAATGC CGCCCATGCA 360
TGGAGAAAAG GAGGTGTGAA TATGCACCCT GCACAGAGGA CGGGGGTATA AATGCCCATC 420
CTGCAGGGAG GACAGAGTGT GAATGCCTGC CCTGGATGAG GACAGAGGTG TGAATGCCCA 480
CCCTGCATTG AGGACGGATG TTGTGAACAC CTGCCCTCCA CACCCTCTTA TTTGGCCGCT 540
ACACTTCACC AGTGGAGGAC ACTCCAACCT GACTTTCATC AGGGCTCTGC TACCAACTCT 600
CTATCTGACT GACCTCCAGG CCAGTCACTG ACCTCTTTGG GTCTCAGTTT CCACATCTAT 660
AAAATGGGAG AATAATACCT TCTCATGGCA TGTCACGTCA GTCTGGGTTG GGAGTCTGAA 720
TCCAGGACCA GTTCCTTCCA CAACCCCAAG GTCTTCCTGA CACTGCTCCC AGCCCCTAGG 780
CCTTCCCCAT CACCTCTCCC CACGCTTCTA GTTAGCACTG GGGTAGATGC TTCAGGACTG 840
ACTCTGCCAC GGAAAGGGGC CAGAGGGCAT AGAGCCTGCC TACTCTCTGC CCCTCCCAAT 900
GAGGCCTTTC CTGTGTTCAC TGCGGCCTAG AGCTCATCAT GAGCCCTTCC TGCCCGTTCT 960
CCCCTTACCA CTCCACTACC AATCAAAACA GGCCCCCAAA AGGTGGGAGG AACTTAGTAC 1020
TGAATTGCTC ATGGCCTGAA GCCTGTGCGG GAGGCCTGTT GCATCCCACA GCCTGCAGGT 1080
GCTGCCCCTG GAGGGCCTAG CATGGCACAG GGCCGGCCAT AGCTTCTGGC TATCAGCAAG 1140
CTCAGCCCCA GCCCTGACGG 1160
|
